Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study

被引：0
|
作者：
Ismael Francisco Aomar-Millán
Juan Salvatierra
Úrsula Torres-Parejo
Naya Faro-Miguez
José Luis Callejas-Rubio
Ángel Ceballos-Torres
María Teresa Cruces-Moreno
Francisco Javier Gómez-Jiménez
José Hernández-Quero
Francisco Anguita-Santos
机构：
[1] San Cecilio University Hospital,Department of Internal Medicine
[2] Hospital Universitario San Cecilio,Department of Rheumatology
[3] San Cecilio University Hospital,Department of Statistics and Operational Research
[4] University of Granada,Department of Infectious Diseases
[5] San Cecilio University Hospital,Department of Intensive Care Unit
[6] San Cecilio University Hospital,undefined
来源：
Internal and Emergency Medicine | 2021年 / 16卷
关键词：
Anakinra; Tocilizumab; Methylprednisolone; Hyperinflammation; Cytokine storm syndrome; COVID-19;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：843 / 852
页数：9
相关论文
共 50 条
  • [31] Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
    Rodriguez-Bano, Jesus
    Pachon, Onimo
    Carratala, Jordi
    Ryan, Pablo
    Jarrin, Inmaculada
    Yllescas, Maria
    Ramon Arribas, Jose
    Berenguer, Juan
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (02) : 244 - 252
  • [32] Anakinra for severe forms of COVID-19: a cohort study
    Huet, Thomas
    Beaussier, Helene
    Voisin, Olivier
    Jouveshomme, Stephane
    Dauriat, Gaelle
    Lazareth, Isabelle
    Sacco, Emmanuelle
    Naccache, Jean-Marc
    Bezie, Yvonnick
    Laplanche, Sophie
    Le Berre, Alice
    Le Pavec, Jerome
    Salmeron, Sergio
    Emmerich, Joseph
    Mourad, Jean-Jacques
    Chatellier, Gilles
    Hayem, Gilles
    LANCET RHEUMATOLOGY, 2020, 2 (07): : E393 - E400
  • [33] Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study
    Kardos, Zsofia
    Szabo, Miklos
    Barath, Zsuzsanna
    Miksi, Agnes
    Olah, Csaba
    Kozma, Adam
    Gergely, Jozsef A.
    Csanky, Eszter
    Szekanecz, Zoltan
    BIOMEDICINES, 2023, 11 (02)
  • [34] USE OF BARICITINIB AND TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19 IN HOSPITALIZED PATIENTS
    Xibille Friedmann, D. X.
    Carrillo Vazquez, S. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 899 - 900
  • [35] Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study
    Roddy, John
    Wells, Daniel
    Schenck, Katharine
    Santosh, Shrihari
    Santosh, Sadashiv
    CRITICAL CARE EXPLORATIONS, 2022, 4 (05)
  • [36] Relative bradycardia in patients with moderate-to-severe COVID-19: a retrospective cohort study
    Takashi Yoshizane
    Atsushi Ishihara
    Teruki Mori
    Akifumi Tsuzuku
    Jun Suzuki
    Toshiyuki Noda
    SN Comprehensive Clinical Medicine, 4 (1)
  • [37] Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
    Reid, Nancy Kierstin
    Joyner, Kayla Rena
    Lewis-Wolfson, Temeka Dawn
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (07) : 769 - 775
  • [38] Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study
    Rossi, Benjamin
    Nguyen, Lee S.
    Zimmermann, Philippe
    Boucenna, Faiza
    Dubret, Louis
    Baucher, Louise
    Guillot, Helene
    Bouldouyre, Marie-Anne
    Allenbach, Yves
    Salem, Joe-Elie
    Barsoum, Paul
    Oufella, Arezki
    Gros, Helene
    PHARMACEUTICALS, 2020, 13 (10) : 1 - 11
  • [39] BARICITINIB VERSUS TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19
    Lewis-Wolfson, Temeka
    Joyner, Kayla
    Reid, Nancy
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 191 - 191
  • [40] Efficacy of Additional Corticosteroids After Dexamethasone Treatment for Moderate to Severe COVID-19: An Observational Study
    Fukuda, Yosuke
    Mochizuki, Kaoru
    Ijichi, Miharu
    Homma, Tetsuya
    Tanaka, Akihiko
    Sagara, Hironori
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
12345